AZN logo

AstraZeneca PLC (AZN) Selling, General & Administrative Expenses

Annual SG&A:

$20.53B+$2.31B(+12.68%)
December 31, 2024

Summary

  • As of today (October 3, 2025), AZN annual SG&A is $20.53 billion, with the most recent change of +$2.31 billion (+12.68%) on December 31, 2024.
  • During the last 3 years, AZN annual SG&A has risen by +$4.94 billion (+31.70%).
  • AZN annual SG&A is now at all-time high.

Performance

AZN SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNincome statement metrics

Quarterly SG&A:

$144.69M+$9.17M(+6.77%)
June 30, 2025

Summary

  • As of today (October 3, 2025), AZN quarterly SG&A is $144.69 million, with the most recent change of +$9.17 million (+6.77%) on June 30, 2025.
  • Over the past year, AZN quarterly SG&A has increased by +$12.69 million (+9.62%).
  • AZN quarterly SG&A is now -95.86% below its all-time high of $3.49 billion, reached on December 31, 2009.

Performance

AZN Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNincome statement metrics

TTM SG&A:

$17.13B+$5.18B(+43.29%)
June 30, 2025

Summary

  • As of today (October 3, 2025), AZN TTM SG&A is $17.13 billion, with the most recent change of +$5.18 billion (+43.29%) on June 30, 2025.
  • Over the past year, AZN TTM SG&A has increased by +$16.59 billion (+3066.91%).
  • AZN TTM SG&A is now -75.97% below its all-time high of $71.30 billion.

Performance

AZN TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAZNincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

AZN Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+12.7%+9.6%+3066.9%
3Y3 Years+31.7%+12.2%+3340.4%
5Y5 Years+71.3%+39.1%+4385.1%

AZN Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+31.7%-7.3%+14.8%at high+381.8%
5Y5-Yearat high+72.6%-7.3%+46.1%-1.4%+381.8%
All-TimeAll-Timeat high>+9999.0%-95.9%>+9999.0%-76.0%+381.8%

AZN Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$144.69M(+6.8%)
$566.88M(+2.3%)
Mar 2025
-
$135.52M(-4.3%)
$554.19M(+0.1%)
Dec 2024
$20.53B(+12.7%)
$141.67M(-2.3%)
$553.67M(-0.6%)
Sep 2024
-
$145.00M(+9.8%)
$557.00M(+3.0%)
Jun 2024
-
$132.00M(-2.2%)
$541.00M(+0.2%)
Mar 2024
-
$135.00M(-6.9%)
$540.00M(+0.2%)
Dec 2023
$18.22B(+1.3%)
$145.00M(+12.4%)
$539.00M(-2.0%)
Sep 2023
-
$129.00M(-1.5%)
$550.00M(+0.5%)
Jun 2023
-
$131.00M(-2.2%)
$547.00M(+0.4%)
Mar 2023
-
$134.00M(-14.1%)
$545.00M(+1.7%)
Dec 2022
$17.98B(+15.4%)
$156.00M(+23.8%)
$536.00M(+6.3%)
Sep 2022
-
$126.00M(-2.3%)
$504.00M(+1.2%)
Jun 2022
-
$129.00M(+3.2%)
$498.00M(+5.5%)
Mar 2022
-
$125.00M(+0.8%)
$472.00M(+5.8%)
Dec 2021
$15.59B(+31.1%)
$124.00M(+3.3%)
$446.00M(+3.5%)
Sep 2021
-
$120.00M(+16.5%)
$431.00M(+5.1%)
Jun 2021
-
$103.00M(+4.0%)
$410.00M(-0.2%)
Mar 2021
-
$99.00M(-9.2%)
$411.00M(+3.0%)
Dec 2020
$11.90B(-0.7%)
$109.00M(+10.1%)
$399.00M(+4.5%)
Sep 2020
-
$99.00M(-4.8%)
$382.00M(+3.0%)
Jun 2020
-
$104.00M(+19.5%)
$371.00M(+6.6%)
Mar 2020
-
$87.00M(-5.4%)
$348.00M(+2.7%)
Dec 2019
$11.98B(+9.1%)
$92.00M(+4.5%)
$339.00M(-0.3%)
Sep 2019
-
$88.00M(+8.6%)
$340.00M(+4.6%)
Jun 2019
-
$81.00M(+3.8%)
$325.00M(-0.9%)
Mar 2019
-
$78.00M(-16.1%)
$328.00M(-0.9%)
Dec 2018
$10.98B(+4.2%)
$93.00M(+27.4%)
$331.00M(+2.5%)
Sep 2018
-
$73.00M(-13.1%)
$323.00M(-0.9%)
Jun 2018
-
$84.00M(+3.7%)
$326.00M(+3.8%)
Mar 2018
-
$81.00M(-4.7%)
$314.00M(+1.3%)
Dec 2017
$10.54B(+8.3%)
$85.00M(+11.8%)
$310.00M(+0.6%)
Sep 2017
-
$76.00M(+5.6%)
$308.00M(0.0%)
Jun 2017
-
$72.00M(-6.5%)
$308.00M(-5.8%)
Mar 2017
-
$77.00M(-7.2%)
$327.00M(+0.3%)
Dec 2016
$9.74B(-15.4%)
$83.00M(+9.2%)
$326.00M(-4.7%)
Sep 2016
-
$76.00M(-16.5%)
$342.00M(-0.9%)
Jun 2016
-
$91.00M(+19.7%)
$345.00M(+2.1%)
Mar 2016
-
$76.00M(-23.2%)
$338.00M(-0.3%)
Dec 2015
$11.52B(-13.6%)
$99.00M(+25.3%)
$339.00M(+3.4%)
Sep 2015
-
$79.00M(-6.0%)
$328.00M(-2.4%)
Jun 2015
-
$84.00M(+9.1%)
$336.00M(+2.1%)
Mar 2015
-
$77.00M(-12.5%)
$329.00M(+1.5%)
Dec 2014
$13.32B(+6.5%)
$88.00M(+1.1%)
$324.00M(-89.2%)
Sep 2014
-
$87.00M(+13.0%)
$3.01B(-45.1%)
Jun 2014
-
$77.00M(+6.9%)
$5.48B(-31.2%)
Mar 2014
-
$72.00M(-97.4%)
$7.96B(-23.7%)
Dec 2013
$12.51B(+23.2%)
$2.77B(+8.3%)
$10.44B(+2.4%)
Sep 2013
-
$2.56B(-0.2%)
$10.20B(+1.2%)
Jun 2013
-
$2.56B(+0.8%)
$10.08B(+1.5%)
Mar 2013
-
$2.54B(+0.6%)
$9.93B(+0.6%)
Dec 2012
$10.16B(-11.7%)
$2.53B(+3.7%)
$9.87B(-6.0%)
Sep 2012
-
$2.44B(+1.1%)
$10.50B(-2.8%)
Jun 2012
-
$2.41B(-2.8%)
$10.80B(-5.4%)
Mar 2012
-
$2.48B(-21.4%)
$11.42B(-1.6%)
Dec 2011
$11.51B(+6.7%)
$3.16B(+14.9%)
$11.61B(+15.7%)
Sep 2011
-
$2.75B(-9.3%)
$10.04B(-2.2%)
Jun 2011
-
$3.03B(+13.5%)
$10.26B(+7.1%)
Mar 2011
-
$2.67B(+68.4%)
$9.58B(+2.6%)
DateAnnualQuarterlyTTM
Dec 2010
$10.78B(-7.3%)
$1.59B(-46.7%)
$9.34B(-17.0%)
Sep 2010
-
$2.98B(+26.6%)
$11.25B(+2.2%)
Jun 2010
-
$2.35B(-3.2%)
$11.01B(-0.6%)
Mar 2010
-
$2.43B(-30.5%)
$11.07B(-0.1%)
Dec 2009
$11.63B(+3.8%)
$3.49B(+27.7%)
$11.08B(+10.0%)
Sep 2009
-
$2.74B(+13.2%)
$10.08B(+2.9%)
Jun 2009
-
$2.42B(-0.8%)
$9.79B(-3.9%)
Mar 2009
-
$2.44B(-2.1%)
$10.19B(-3.1%)
Dec 2008
$11.20B(+5.6%)
$2.49B(+1.7%)
$10.51B(-3.7%)
Sep 2008
-
$2.45B(-13.0%)
$10.91B(-0.9%)
Jun 2008
-
$2.81B(+1.9%)
$11.01B(+5.0%)
Mar 2008
-
$2.76B(-4.5%)
$10.49B(+5.5%)
Dec 2007
$10.61B(+13.8%)
$2.89B(+13.6%)
$9.94B(+41.0%)
Sep 2007
-
$2.55B(+11.2%)
$7.05B(+56.5%)
Jun 2007
-
$2.29B(+3.3%)
$4.51B(+103.3%)
Mar 2007
-
$2.22B(>+9900.0%)
$2.22B(>+9900.0%)
Dec 2006
$9.32B(+4.7%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2006
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2006
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2006
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2005
$8.91B(+5.5%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2005
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2005
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2005
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2004
$8.45B(+11.8%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2004
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2004
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2004
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2003
$7.55B(+23.1%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2003
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2003
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2003
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2002
$6.14B(+10.6%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2002
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2002
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2002
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2001
$5.55B(+6091.9%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2001
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2001
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2001
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2000
$89.62M(-98.2%)
$0.00(0.0%)
$62.87M(-93.8%)
Sep 2000
-
$0.00(0.0%)
$1.01B(-54.2%)
Jun 2000
-
$0.00(-100.0%)
$2.20B(-38.7%)
Mar 2000
-
$62.87M(-93.3%)
$3.59B(+1.8%)
Dec 1999
$4.92B(+24.9%)
$944.00M(-20.9%)
$3.53B(+36.6%)
Sep 1999
-
$1.19B(-14.1%)
$2.58B(+85.9%)
Jun 1999
-
$1.39B(+47.8%)
$1.39B(+47.8%)
Dec 1998
$3.94B(>+9900.0%)
-
-
Jun 1998
-
$939.50M(+36.1%)
$939.50M(+36.1%)
Dec 1997
$36.37M(-3.5%)
-
-
Dec 1996
$37.68M(-18.7%)
-
-
Dec 1995
$46.36M(-17.6%)
-
-
Jun 1995
-
$690.40M
$690.40M
Dec 1994
$56.28M(+8.7%)
-
-
Dec 1993
$51.77M(+6.7%)
-
-
Dec 1992
$48.53M(-3.9%)
-
-
Dec 1991
$50.52M(+4.8%)
-
-
Dec 1990
$48.22M
-
-

FAQ

  • What is AstraZeneca PLC annual SG&A?
  • What is the all-time high annual SG&A for AstraZeneca PLC?
  • What is AstraZeneca PLC annual SG&A year-on-year change?
  • What is AstraZeneca PLC quarterly SG&A?
  • What is the all-time high quarterly SG&A for AstraZeneca PLC?
  • What is AstraZeneca PLC quarterly SG&A year-on-year change?
  • What is AstraZeneca PLC TTM SG&A?
  • What is the all-time high TTM SG&A for AstraZeneca PLC?
  • What is AstraZeneca PLC TTM SG&A year-on-year change?

What is AstraZeneca PLC annual SG&A?

The current annual SG&A of AZN is $20.53B

What is the all-time high annual SG&A for AstraZeneca PLC?

AstraZeneca PLC all-time high annual SG&A is $20.53B

What is AstraZeneca PLC annual SG&A year-on-year change?

Over the past year, AZN annual SG&A has changed by +$2.31B (+12.68%)

What is AstraZeneca PLC quarterly SG&A?

The current quarterly SG&A of AZN is $144.69M

What is the all-time high quarterly SG&A for AstraZeneca PLC?

AstraZeneca PLC all-time high quarterly SG&A is $3.49B

What is AstraZeneca PLC quarterly SG&A year-on-year change?

Over the past year, AZN quarterly SG&A has changed by +$12.69M (+9.62%)

What is AstraZeneca PLC TTM SG&A?

The current TTM SG&A of AZN is $17.13B

What is the all-time high TTM SG&A for AstraZeneca PLC?

AstraZeneca PLC all-time high TTM SG&A is $71.30B

What is AstraZeneca PLC TTM SG&A year-on-year change?

Over the past year, AZN TTM SG&A has changed by +$16.59B (+3066.91%)
On this page